https://vimeo.com/718371173
10 Years of SARRP at University of Pennsylvania
read more
User Spotlights
A Dermatologist’s Experience
Recently, Dr. Steven Davis shared his experience of using RADiant in Dermatology Times. See his piece below. Steven A Davis, M.D., is a board-certified dermatologist and Medical Director of the Dermatology & Laser Center of San Antonio.
RADiant in Action: The Dermatology & Laser Center of San Antonio
Over his career, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, has performed more than 25,000 skin cancer operations. While surgery is still the primary treatment, it's not always the best option for the patient, especially...
User Spotlight: Léonard de Vinci Centre treating non-melanoma skin cancers with Xstrahl 100
Non-melanoma skin cancers (NMSC) are the most commonly diagnosed cancers in the world. Despite their relatively low malignant potential and mortality rate, NMSC are associated with a high morbidity and substantial treatment cost, and they significantly affect patient...
User Spotlight: Just Skin Treatment Clinic uses the Xstrahl 100 for the treatment of skin cancer in Australia
The Xstrahl 100 is perfectly suited for the treatment of non-melanoma skin cancers, and with Australia recording skin cancer rates of 2 in every 3 adults, the need for an effective and versatile treatment method is essential. With the aim to offer non-melanoma skin...
Queen’s University Belfast is the latest Xstrahl User Spotlight
Recently, the Radiobiology Research Group from the Centre for Cancer Research and Cell Biology at Queen’s University Belfast published a series of articles using SARRP to explore different translationally focused experimental approaches. The group, led by Prof Kevin Prise and Dr Karl Butterworth, have published three back to back papers within three months which reflect the interests of the research program in nanoparticle theranostics, bystander signaling and novel combination therapy.
Contact Us